Literature DB >> 8140483

Development of a polymerase chain reaction assay for the detection of Haemophilus ducreyi.

S R Johnson1, D H Martin, C Cammarata, S A Morse.   

Abstract

BACKGROUND AND OBJECTIVES: Haemophilus ducreyi, the causative agent of chancroid is a fastidious organism difficult to culture and identify. Consequently, culture is an insensitive method for diagnosis. The polymerase chain reaction (PCR) offers a sensitive and specific nonculture method for the detection of bacterial pathogens. STUDY
DESIGN: A polymerase chain reaction (PCR) assay was developed to detect the presence of Haemophilus ducreyi. A pair of primers was selected from sequences of an anonymous fragment of DNA cloned from H. ducreyi. The primers were tested in amplification reactions with both purified DNA and lysed organisms for their ability to detect H. ducreyi, and with DNA from a variety of different bacteria for their specificity. The utility of the primers for the detection of H. ducreyi in samples taken from genital ulcers was also tested and compared with culture.
RESULTS: PCR was positive for 62% of the specimens that were culture-positive, however, PCR was also positive for 49% of the culture-negative specimens. Comparison of specimens that were dark field positive for T. pallidum and PCR-positive with those that were culture-positive for herpes simplex virus and PCR positive suggested that PCR was giving true and not random positive results. Additional studies demonstrated that the failure of PCR to detect H. ducreyi in all of the culture-positive specimens probably resulted from inhibitors of the Taq DNA polymerase that were present in the nucleic acids extracted from the clinical specimen.
CONCLUSION: PCR should be a useful method for the detection of H. ducreyi in genital lesions, especially where culture sensitivity is poor. However, the presence of unidentified Taq polymerase inhibitors in some ulcers specimens require the development of improved methods for specimen handling.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140483     DOI: 10.1097/00007435-199401000-00004

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

Review 1.  Diagnostic tests for chancroid.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

2.  Simplified PCR for detection of Haemophilus ducreyi and diagnosis of chancroid.

Authors:  B West; S M Wilson; J Changalucha; S Patel; P Mayaud; R C Ballard; D Mabey
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

3.  Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi.

Authors:  P A Totten; J M Kuypers; C Y Chen; M J Alfa; L M Parsons; S M Dutro; S A Morse; N B Kiviat
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Alterations in sample preparation increase sensitivity of PCR assay for diagnosis of chancroid.

Authors:  S R Johnson; D H Martin; C Cammarata; S A Morse
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

5.  Asymptomatic carriage of Haemophilus ducreyi confirmed by the polymerase chain reaction.

Authors:  S Hawkes; B West; S Wilson; H Whittle; D Mabey
Journal:  Genitourin Med       Date:  1995-08

Review 6.  Chancroid: clinical manifestations, diagnosis, and management.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

Review 7.  Chancroid and Haemophilus ducreyi: an update.

Authors:  D L Trees; S A Morse
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

8.  Polymerase chain reaction detection of Haemophilus ducreyi DNA.

Authors:  D J Roesel; L Gwanzura; P R Mason; M Joffe; D A Katzenstein
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

Review 9.  Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans.

Authors:  Niels Nørskov-Lauritsen
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.